| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/17/2006 | WO2004110359A3 Fusion proteins for the treatment of cns |
| 08/17/2006 | WO2004094647A3 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 08/17/2006 | WO2004093816A3 Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent |
| 08/17/2006 | WO2004067553A3 Tolerance-induced targeted antibody production |
| 08/17/2006 | WO2003104391A3 Antibacterial targets in alloiococcus otitidis |
| 08/17/2006 | WO2003075860A3 Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof |
| 08/17/2006 | WO2003066831A3 Angiogenesis genes |
| 08/17/2006 | WO2003066071A8 Formulations comprising psychotropic drugs and selenium |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183931 Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 08/17/2006 | US20060183929 Crystals of the sodium salt of pravastatin |
| 08/17/2006 | US20060183928 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 08/17/2006 | US20060183921 Pharmaceutically active compounds and methods of use |
| 08/17/2006 | US20060183918 Beta 2-adrenergic receptor agonists |
| 08/17/2006 | US20060183913 N-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when NO is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 08/17/2006 | US20060183911 Pyridones useful as inhibitors of kinases |
| 08/17/2006 | US20060183910 Pharmaceutical compositions of 4-amino-2-(3-methyl-2,6-dioxo-piperidin-3-yl)-isoindole-1,3-dione |
| 08/17/2006 | US20060183909 Compositions derived from quinoline and quinoxaline, preparation and use thereof |
| 08/17/2006 | US20060183906 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 08/17/2006 | US20060183905 Derivatives of 4-(thio-or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 08/17/2006 | US20060183904 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers |
| 08/17/2006 | US20060183902 Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 08/17/2006 | US20060183900 enzyme inhibitors such as 2-{4-[4-(1H-Pyrrolo[2,3-b]pyridin-3-yl)-pyrimidin-2-ylamino]-phenyl}-ethanol, useful in treating or ameliorating a kinase mediated, angiogenesis-mediated or hyperproliferative disorder |
| 08/17/2006 | US20060183899 Having a predominantly cis configuration by coupling an S-oxide of a 2-oxymethyl- thiolane, dithiolane or oxathiolane with a nucleoside base in the presence of a tertiary amine, a Lewis acid of a Group 1B or 2B metal catalyst and deprotecting the intermediate formed |
| 08/17/2006 | US20060183890 Isopropanolate of azithromycin and method of manufacturing |
| 08/17/2006 | US20060183886 Ligands to enhance cellular uptake of biomolecules |
| 08/17/2006 | US20060183806 Compositions and methods comprising long-chain, straight-chain 2-amino-3- hydroxyalkanes |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183804 Oxygen-impervious packaging with optional oxygen scavenger, stabilized thyroid hormone compositions and methods for storing thyroid hormone pharmaceutical compositions |
| 08/17/2006 | US20060183803 L-aspartic acid for the treatment of assorted health problems |
| 08/17/2006 | US20060183802 Compositions and methods for treating amyotrophic lateral sclerosis (ALS) |
| 08/17/2006 | US20060183801 Method of preventing or treating breast, prostate and/or cervical cancer with n, n-dimethylglycine |
| 08/17/2006 | US20060183800 Methods and fluorinated compositions for treating amyloid-related diseases |
| 08/17/2006 | US20060183799 Biologically active oils |
| 08/17/2006 | US20060183798 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent |
| 08/17/2006 | US20060183797 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 08/17/2006 | US20060183796 Method for the medicinal prophylaxis of cholinesterase inhibitor intoxication, and active substances and medicaments suitable therefor |
| 08/17/2006 | US20060183795 Use of a monocarbamate enantiomer substantially free of other enantiomers or an enantiomeric mixture wherein a monocarbamate enantiomer predominates in preventing or treating neuropathic pain |
| 08/17/2006 | US20060183794 Drug composition containing nf-kb inhibitor |
| 08/17/2006 | US20060183793 Method of treating hematologic tumors and cancers |
| 08/17/2006 | US20060183792 Substituted thienyl and furyl acylguanidines and methods of their use as beta-secretase modulators |
| 08/17/2006 | US20060183791 Substituted p-diaminobenzene derivatives |
| 08/17/2006 | US20060183790 e.g. N-[amino(imino)methyl]-2-[2-(4-phenoxyphenyl)-5-phenyl-1H-pyrrol-1-yl]acetamide; beta -amyloid deposits and neurofibrillary tangles; cognition activator, neurodegenerative diseases; Alzheimer's disease, Down's syndrome |
| 08/17/2006 | US20060183789 Methods for preventing and treating obesity in patients with mc4 receptor mutations |
| 08/17/2006 | US20060183788 Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| 08/17/2006 | US20060183787 Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| 08/17/2006 | US20060183786 Injectable long-acting analgesic composition comprising an ester derivative of ketorolac |
| 08/17/2006 | US20060183785 For the treatment of pain; epilepsy, manic depression, bipolar disorder, depression, anxiety and diabetic neuropathy; 5-Methyl-1-[2'-(trifluoromethoxy)-1,1'-biphenyl-3-yl]-1H-pyrazole-3-carboxamide |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183783 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 08/17/2006 | US20060183782 3-[5-(4-methylbenzylidene)-4-oxo-2-thioxothiazolidin-3-yl]-N-(4-sulfamoylphenyl)-propionamide; compounds are protein tyrosine phosphatse inhibitors; antiinflmmatory, anticarcinogenic agents |
| 08/17/2006 | US20060183781 Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers |
| 08/17/2006 | US20060183780 Lipoxygenase (e.g. 15-lipoxygenase) inhbitors; less toxic; longer acting; more potent; fewer side effects; easily absorbed; higher oral bioavailability and/or lower clearance; 4-Methyl-1-(pyridine-2-sulfonyl)pyrazole-3-carboxylic acid (2-chloro-4-fluorophenyl)amide |
| 08/17/2006 | US20060183779 Dabigatran etexilate and its methanesulfonic acid salt |
| 08/17/2006 | US20060183778 Osteogenesis-promotion enhancer and method of screening the same |
| 08/17/2006 | US20060183777 Process for halomethyl ethers of hydroxyiminomethyl quaternary pyridinium salts |
| 08/17/2006 | US20060183776 An orally administrable mixture comprising donepezil hydrochloride, polyvinylpyrrolidone, sorbitol solution, citric acid and sodium citrate, sodium benzoate and methylparaben, propylene glycol, sodium metabisulfite; treating Parkinson's disease, cognitive impairments, dementia |
| 08/17/2006 | US20060183775 Using N((1-(2-(4-hydroxyphenyl)ethyl)-4-piperidinyl)methyl)-1-isopropyl-1H-indazole-3-carboxamide hydrochloride to treat neuropathic pain caused by trauma, multiple sclerosis, immunodeficiency; ischemia, diabetes and neuralgia |
| 08/17/2006 | US20060183774 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 08/17/2006 | US20060183773 Uses of methylphenidate derivatives |
| 08/17/2006 | US20060183772 To inhibit tumor growth in an animal; to induce apoptosis |
| 08/17/2006 | US20060183771 Novel combination of selective factor VIIa and/or factor XIa inhibitors and selective plasma kallikrein inhibitors |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183769 Chemotherapy-induced nausea and vomiting (CINV), diarrhea-predominant Irritable Bowel Syndrome (IBS-D); 5-HT3 inhibitors; N-[3-(2-Methylimidazol-1-yl)propyl]-2-phenylbenzoxazole-4-carboxamide |
| 08/17/2006 | US20060183768 Compounds |
| 08/17/2006 | US20060183767 Using imiquimod; rubbing into surface |
| 08/17/2006 | US20060183766 administering micronized rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid in a high povidone-containing formulation; tablet; kit |
| 08/17/2006 | US20060183765 Methods of treating cancer using an FPT inhibitor and antineoplastic agents |
| 08/17/2006 | US20060183764 Combination of gh secret agogues and pde4 inhibitors for the treatment of alzheimers disease |
| 08/17/2006 | US20060183763 Novel pyrrolidyl derivatives of heteroaromatic compounds |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183761 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 08/17/2006 | US20060183760 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 08/17/2006 | US20060183759 Tissue transglutaminase inhibitors |
| 08/17/2006 | US20060183758 Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183756 7-Difluoromethyl-5-(4-trifluoromethyl-phenyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (2-chloro-5-sulfamoyl-thiophen-3-yl)-amide; metabotropic glutamate receptors antagonist; anxiolitic, analgesic, hyperglycemic agent; absorption, advantages in pharmacokinetics in distribution transport to the brain |
| 08/17/2006 | US20060183755 Tyrosine kinase inhibitors |
| 08/17/2006 | US20060183754 Amide bridged piphenyl or biazaphenyl derivatives |
| 08/17/2006 | US20060183753 Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
| 08/17/2006 | US20060183752 Process for preparing 2, 3-disubstituted indoles |
| 08/17/2006 | US20060183751 Pyrazole compounds |
| 08/17/2006 | US20060183750 Treatment of metastasized tumors |
| 08/17/2006 | US20060183749 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/17/2006 | US20060183748 Identification of compounds that inhibit replication of human immunodeficiency virus |
| 08/17/2006 | US20060183747 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/17/2006 | US20060183746 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 08/17/2006 | US20060183745 Vanilloid receptor ligands and their use in treatments |
| 08/17/2006 | US20060183744 Method for treating depression and/or anxiety |
| 08/17/2006 | US20060183743 administering 6-Hydroxy-1,2,3,4-tetrahydro-naphthalene-2(-)-carboxylic acid{1-[4-(3-hydroxyphenyl)-(3R)-(4R)-trans-dimethyl-piperidinylmethyl]-(2S)-methylpropyl}-amide, for the treatment of drug abuse and dependence |
| 08/17/2006 | US20060183742 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183740 Novel salt form of a dopamine agonist |
| 08/17/2006 | US20060183739 Carbonyl compounds |
| 08/17/2006 | US20060183738 Crystalline forms of nevirapine |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | US20060183736 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 08/17/2006 | US20060183735 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 08/17/2006 | US20060183734 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 08/17/2006 | US20060183733 Treating microvasculature diseases with acetyl cholinesterase inhibitors |